# A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Study · id `cardio:ct-nct01860729` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01860729](<https://clinicaltrials.gov/study/NCT01860729>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01860729

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 589 participants.

## Technical summary

Registry record NCT01860729. Randomized; double masking; primary purpose treatment. Start 2013-05-13 (actual); primary completion 2015-05-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 589 participants (enrolled count; ClinicalTrials.gov record NCT01860729, source copy `cardio:ctgov-nct01860729-2020-05-29`, retrieved 2026-10-31)
- Started: 2013-05-13 (actual) (ClinicalTrials.gov record NCT01860729, source copy `cardio:ctgov-nct01860729-2020-05-29`, retrieved 2026-10-31)
- Primary completion: 2015-05-29 (actual) (ClinicalTrials.gov record NCT01860729, source copy `cardio:ctgov-nct01860729-2020-05-29`, retrieved 2026-10-31)
- Completion: 2015-08-20 (actual) (ClinicalTrials.gov record NCT01860729, source copy `cardio:ctgov-nct01860729-2020-05-29`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01860729-2020-05-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)
- Condition: Hypercholesterolemia
- Intervention (Drug): Anacetrapib
- Intervention (Drug): Placebo
- Lead sponsor: Merck Sharp & Dohme LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as the lead sponsor: Merck Sharp & Dohme LLC (`cardio:org-merck-sharp-dohme-llc`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol (`cardio:pubmed-28624096`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a77418cbf8b202aa3ae3cdba441682cff2892b92c981e13d7949ca5b78229f3c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
